The International Journal of Tuberculosis and Lung Disease

The tobacco pandemic [Editorial]
pp. 85-86(2)
Author: Sir John Crofton

Good news and not such good news [Editorial]
pp. 87-87(1)
Author: Michael D. Iseman

Dilemmas and realities in the laboratory diagnosis of tuberculosis in low income countries [Editorial]
pp. 88-89(2)
Authors: Leonid Heifets; Pamela Lindholm-Levy

Risk from tobacco and potentials for health gain
pp. 90-99(10)
Author: R. Doll

Physicians can make a difference with smokers: evidence-based clinical approaches
pp. 100-112(13)
Author: R.L. Richmond

Are low income countries targets of the tobacco industry? [Counterpoint]
pp. 113-118(6)
Author: E. Dali

Bioavailability of rifampicin, isoniazid and pyrazinamide in a triple drug formulation: comparison of plasma and urine kinetics
pp. 119-125(7)
Authors: P. Gurumurthy; G. Ramachandran; S. Vijayalakshmi; A.K. Hemanth Kumar; P. Venkatesan; V. Chandrasekaran; V. Vjayasekaran; V. Kumaraswami; R. Prabhakar

Assessment of a combined preparation of isoniazid, rifampicin and pyrazinamide (Rifater®) in the initial phase of chemotherapy in three 6-month regimens for smear-positive pulmonary tuberculosis: a five-year follow-up report
pp. 126-132(7)
Author: S.K. Teo

Pharmacokinetics of pyrazinamide in children suffering from pulmonary tuberculosis
pp. 133-137(5)
Authors: V. Roy; U. Tekur; K. Chopra

Microcolony detection in 7H11 thin layer culture is an alternative for rapid diagnosis of Mycobacterium tuberculosis infection
pp. 138-142(5)
Authors: G.I. Mejia; L. Castrillon; H. Trujillo; J.A. Robledo

Drug susceptibility of Mycobacterium tuberculosis in a rural area of Bangladesh and its relevance to the national treatment regimens
pp. 143-148(6)
Authors: A. Van Deun; K.J.M. Aung; S. Chowdhury; S. Saha; A. Pankaj; A. Ashraf; L. Rigouts; K. Fissette; F. Portaels

Drug-resistant strains of Mycobacterium tuberculosis isolated in Russia
pp. 149-152(4)
Authors: V.N. Stepanshina; E.A. Panfertsev; O.V. Korobova; I.G. Shemyakin; Y.u.G. Stepanshin; I.M. Medvedeva; I.R. Dorozhkova

Use of incentives to increase compliance for TB screening in a population of intravenous drug users
pp. 153-155(3)
Authors: J.M. FitzGerald; D.M. Patrick; S. Strathdee; M. Rekart; R.K. Elwood; M.T. Schecter; J. Montaner; M. O'Shaughnessy; the Vancouver Injection Drug Use Study Group

Altitude: a determinant for tuberculosis in Kenya?
pp. 156-161(6)
Authors: J.R. Mansoer; D.K. Kibuga; M.W. Borgdorff

Lymph node tuberculosis in the suburbs of Paris: 59 cases in adults not infected by the human immunodeficiency virus
pp. 162-165(4)
Authors: O. Fain; O. Lortholary; M. Djouab; I. Amoura; P. Babinet; J. Beaudreuil; P. Boudon; J. Desrues; J. Glowinski; F. Lhote; D. Malbec; E. Mathieu; C. White; L. Guillevin; M. Thomas

Innate resistance to tuberculosis: revisiting Max Lurie genetic experiments in rabbits
pp. 166-168(3)
Author: E. Werneck-Barroso

Identification of Mycobacterium shimoidei by molecular techniques: case report and summary of the literature [Case Study]
pp. 169-173(5)
Authors: B. Mayall; V. Gurtler; L. Irving; A. Marzec; D. Leslie

Correspondence
pp. 174-176(3)